A new collaboration between the Medicines and Healthcare Products Regulatory Agency (MHRA) and Barts Health NHS Trust has led to introduction a new DNA sequencing technology that will diagnose bacterial infections quicker and accurately in hospitals across the UK.
Here, we find out about Yourgene Health, a molecular diagnostics company with products and technologies that enable precision medicine in oncology from bench to clinic.
Jean-Pierre Leburton, and Olgica Milenkovic, Professors of Electrical and Computer Engineering at the University of Illinois at Urbana-Champaign, discuss how big data processing via bio-sensing, and blue energy production revolutionise solid-state nanopores.
Associate Professor Ken Tachibana, discloses how prenatal ambient fine particle exposure disrupts DNA methylation and subsequent gene expression in the foetal development stage.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, provides a portrait of a ground-breaking technology, next-generation sequencing, starting with a brief snapshot.
Richie Kohman, Synthetic Biology Platform Lead at Wyss Institute at Harvard, explains the use of next-generation sequencing to analyse biological tissues in a spatially resolved context.
Professor Afaf El-Sagheer and Professor Tom Brown from the Department of Chemistry, Suez University and Oxford University describe their research, including the application of ‘click chemistry’ conjugation techniques to DNA.
Virginia Edgcomb from the Woods Hole Oceanographic Institution discusses deep ocean drilling, a process that reveals earth history, geological processes and a deep biosphere.
Neil Osheroff from the Vanderbilt University School of Medicine is working to overcome drug resistance and revitalise the use of established targets for antibacterial agents, as we discover here.
Dr Kim Hammond-Kosack at Rothamsted Research highlights an aspect of plant pathology that concerns the importance of finding new ways to disarm old enemies in wheat diseases.
Editor of Open Access Government, Jonathan Miles, spoke to Juan Meza at the National Science Foundation about the launch of four new centres to bring mathematical perspectives to the biological search for the Rules of Life.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides a cancer focus, in particular, she details breakthrough technologies that allow leveraging biomarkers for oncology.
